Decision Diagnostics Subsidiary Makes Move and Sues Two Johnson and Johnson Divisions for False Advertising in Ongoing Battle

Decision Diagnostics Subsidiary Makes Move and Sues Two Johnson and Johnson 
Divisions for False Advertising in Ongoing Battle 
LOS ANGELES, CA -- (Marketwired) -- 08/01/13 --  Decision Diagnostics
Corp. (OTCBB: DECN), the exclusive worldwide sales, service and
regulatory processes agent for the Shasta GenStrip(TM), the Green
Glucose Test Strip, specifically designed to work with Johnson &
Johnson's (NYSE: JNJ) LifeScan Ultra family of glucose testing
meters, announced today the filing of counterclaims by its subsidiary
Pharma Tech Solutions, Inc. for false and misleading advertising
against two of Johnson & Johnson, Inc. ("J&J") wholly owned
subsidiaries, Lifescan, Inc., and Lifescan Scotland, LTD
(collectively "Lifescan"). The company and its Pharma Tech Solutions,
Inc. ("Pharma Tech") subsidiary have been in patent litigation with
the Lifescan subsidiaries since September 2011. 
J&J's wholly owned subsidiary Lifescan manufactures and sells blood
glucose monitoring systems, which include meters and test strips,
under the OneTouch(R) Ultra(R) brand name. Lifescan is the market
share leader in the at-home glucose testing market. The company's
Pharma Tech subsidiary competes directly with J&J Lifescan in the
market for at-home glucose test strips by offering the Shasta
GenStrip(TM), a unique diagnostic testing strip, that has received
FDA clearance for at-home use with certain OneTouch(R) Ultra(R)
meters. The GenStrip(TM) is a lower-cost alternative to the
OneTouch(R) Ultra(R) test strip that works with specific OneTouch(R)
Ultra(R) meters and costs significantly less than the J&J Lifescan
product.  
In 2012, immediately following FDA clearance of the GenStrip(TM),
Lifescan moved the Federal District Court to enjoin sales and
distribution of the competitive GenStrip(TM). While a Federal
District Court for the Northern District of California granted
Lifescan a preliminary injunction, the Federal Circuit Court quickly
stayed the injunction and the matter currently awaits a near term
ruling.  
Today, Pharma Tech seeks leave from the District Court, in the court
room of a judge new to the aforementioned September 2011 case, to
amend its counterclaim against J&J Lifescan, based on
anti-competitive actions by Lifescan, so that a claim for fals
e
advertising can be added. 
J&J Lifescan promotes its OneTouch(R) Ultra(R) system as having
"Double Sure technology," which supposedly "automatically checks...
each blood a sample twice to assure that [the user is] receiving the
most accurate results." By this representation, J&J Lifescan falsely
conveys to consumers that its OneTouch(R) Ultra(R) system provides
more accurate results than the competition, including the
GenStrip(TM). By virtue of proposed amendment to its counterclaim,
Pharma Tech intends to prove that this representation is misleading
and untrue and that OneTouch(R) Ultra(R) system actually likely
provides less accurate results than much of its competition. 
DECN's Pharma Tech subsidiary is a leading provider of prescription
and non-prescription diagnostics, home testing products for the
chronically ill and a premier developer of revolutionary cell phone
centric e-health products and technologies. The FDA cleared Shasta
GenStrip(TM) product was first introduced to the market in late 2012
as a lower cost (50%) alternative for user/owners of the J&J LifeScan
OneTouch(R) Ultra(R), Ultra2(R) and Ultra Mini(R) glucose meters.  
Forward-Looking Statements: 
 This release contains forward-looking
statements about our business or financial condition that reflect our
assumptions and beliefs based on information currently available. We
can give no assurance that the expectations indicated by such
forward-looking statements will be realized. There may be other risks
and circumstances that we are unable to predict. When used in this
release, words such as "believes," "expects," "forecasts," "intends,"
"projects," "plans," "anticipates," "estimates," "will" and similar
expressions are intended to identify forward-looking statements,
although there may be certain statements not accompanied by such
expressions. 
For further information about Shasta Genstrip, please visit the
company's Web Sites: http://www.decisiondiagnostics.com or
http://www.shastagenstrip.com. The company's Genstrip videos can be
viewed at http://www.pharmatechdirect.com. A new video is currently
in production. 
GenStrip(TM) test strips are a product of Shasta Technologies, LLC
and are not manufactured, distributed, endorsed, or approved by nor
associated with LifeScan(R), Inc. a Johnson & Johnson(R) Company,
manufacturers and distributors of the OneTouch(R) Ultra(R) Family of
Meters and OneTouch(R) Ultra(R) test strips. 
Contacts: 
Keith Berman 
Secretary and CFO 
info@decisiondiagnostics.com 
2660 Townsgate Road 
Suite 300 
Westlake Village, CA 91361 
Ph: 805-446-2973 
Fax: 805-446-1983 
 
 
Press spacebar to pause and continue. Press esc to stop.